Pneumologia Vol. 65 Nr. 1
Journal indexed in SCOPUS and EBSCO
Member of COPE
Impact factor SJR 0.145
Copyright Romanian Society of Pneumology
We want to make exchanges with other publications.
If we are looking into the real problems of chronic obstructive pulmonary disease (COPD) we can find out many current problems unsolved at this moment: it’s a prevalent major medical problem, underdiagnosed, unrecognized, untreated. The current therapies also have their own problems. Monotherapy with bronchodilators is sometimes not sufficient, combinations of different classes of bronchodilators sometimes have not well defined indications and the combination of bronchodilators and inhaled corticosteroids (ICS) is more criticized every day.
Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. According to World Health Organization (WHO), COPD retains the III, IV and V places in upper-middle , lowermiddle and high income countries respectively and by 2020 will attain the third place all over the world. Nonetheless there is still inconsistent research about its pathophysiological mechanisms and treatment. This leads to irreversible alterations not only in patient’s lungs but also has systemic consequences.
Mycobacterium tuberculosis in trachea and bronchial tree causes a serious type of highly contagious infection named endobronchial tuberculosis (EBTB)(1). Irreversible bronchostenosis is an important delayed complication of EBTB(2,3). Anthracotic bronchitis is a bronchopathy characterized by anthracotic pigmentation in mucosa and submucosa of the bronchial tree(4). It is caused by inhalation of smoke made by incomplete biomass combustion or exposure to wood fire(5). Therefore, it is frequent in rural areas where women, in particular, make bread or food in traditional ovens(6).
According to the World Health Organization (WHO) there were 9 million new cases of tuberculosis and 1.5 million deaths from this disease in 2013. About one-third of world’s population has latent tuberculosis, this means that people have been infected by Mycobacterium tuberculosis but are not ill at current time(1). People infected with TB bacteria have a lifetime risk of falling ill with tuberculosis of 10%(2). Tuberculosis is a multisystemic disease with various symptoms and manifestations and can affect any organ or tissue.